Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador for the charity's campaign to ...
Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...
For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...
Lilly recently revised its revenue forecast for 2024 after seeing weaker-than-expected growth for Zepbound and diabetes brand ...
We know that new and complex science, enabled by technology, is driving a veritable scientific renaissance. Biopharma ...
In a move that will raise eyebrows in Washington, Pfizer has hired the former director of the FDA's Center for Drug ...
The MELD Graph tool – developed by a team led by scientists at King's College London (KCL) – could "drastically change" care for around 30,000 people with a particular type of epilepsy in the UK by ...
The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...
The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as a first-line therapy for patients with a ...
Cell therapies are the future of healthcare, why are we struggling to make them at scale?
Mirum Pharma's Ctexli has become the first FDA-approved therapy for cerebrotendinous xanthomatosis (CTX), an ultra-rare form ...
The week has ended with a flurry of M&A in the drug industry, with Cosette Pharmaceuticals agreeing to buy Australia's Mayne ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results